JBS(JBS)
JBS
Analyst ratings reflect Wall Street opinion, not guarantees. Historical accuracy varies by firm and sector.
Price targets are 12-month analyst forecasts. Actual results depend on earnings, market conditions, and sector trends.
| Metric | FY2026E | FY2027E | FY2028E |
|---|---|---|---|
| Revenue Avg | $478.27B | $490.74B | $502.43B |
| Low | $477.54B | $486.80B | $476.99B |
| High | $479.05B | $494.69B | $525.14B |
| EBITDA Avg | $39.64B | $40.68B | $41.64B |
| Low | $39.58B | $40.35B | $39.54B |
| High | $39.71B | $41.00B | $43.53B |
| EBIT Avg | $27.58B | $28.30B | $28.97B |
| Low | $27.54B | $28.07B | $27.50B |
| High | $27.62B | $28.53B | $30.28B |
| Net Income Avg | $7.56B | $8.57B | $11.11B |
| Low | $6.73B | $7.61B | $10.38B |
| High | $8.34B | $9.12B | $11.76B |
| EPS Avg | $7.07 | $8.02 | $10.40 |
| Low | $6.30 | $7.13 | $9.71 |
| High | $7.80 | $8.54 | $11.01 |
| Analysts (Rev / EPS) | 9 / 5 | 9 / 5 | 3 / 2 |
| Metric | Q3 2026 | Q4 2026 | Q1 2027 | Q2 2027 | Q3 2027 | Q4 2027 |
|---|---|---|---|---|---|---|
| Revenue Avg | $123.70B | $125.75B | $115.49B | $117.90B | $126.22B | $131.52B |
| Low | $123.01B | $122.68B | $112.67B | $115.02B | $123.14B | $128.31B |
| High | $124.39B | $127.65B | $117.23B | $119.68B | $128.12B | $133.50B |
| EBITDA Avg | $10.25B | $10.42B | $9.57B | $9.77B | $10.46B | $10.90B |
| Low | $10.20B | $10.17B | $9.34B | $9.53B | $10.21B | $10.63B |
| High | $10.31B | $10.58B | $9.72B | $9.92B | $10.62B | $11.07B |
| EBIT Avg | $7.13B | $7.25B | $6.66B | $6.80B | $7.28B | $7.58B |
| Low | $7.09B | $7.07B | $6.50B | $6.63B | $7.10B | $7.40B |
| High | $7.17B | $7.36B | $6.76B | $6.90B | $7.39B | $7.70B |
| Net Income Avg | $2.13B | $1.87B | $1.25B | $2.19B | $2.21B | $1.71B |
| Low | $2.06B | $1.81B | $1.21B | $2.12B | $2.14B | $1.66B |
| High | $2.17B | $1.90B | $1.27B | $2.24B | $2.25B | $1.74B |
| EPS Avg | $2.08 | $1.83 | $1.22 | $2.15 | $2.16 | $1.67 |
| Low | $2.02 | $1.77 | $1.18 | $2.08 | $2.09 | $1.62 |
| High | $2.13 | $1.86 | $1.24 | $2.19 | $2.21 | $1.71 |
| Analysts (Rev / EPS) | 4 / 3 | 2 / 1 | 2 / 1 | 2 / 1 | 2 / 1 | 2 / 1 |